J. A. Vaz

Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes

Jens Sandahl Christiansen, J. A. Vaz, Željko Metelko et al. · Diabetes Obesity and Metabolism · 2003 · 68 citations

Adding biphasic insulin aspart 30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes

W. M. W. Bebakar, C. C. Chow, Sompongse Suwanwalaikorn et al. · Diabetes Obesity and Metabolism · 2007 · 32 citations

Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study

Surendra Kumar Sharma, Majeed Almustafa, Seungbae Oh et al. · Current Medical Research and Opinion · 2008 · 26 citations

Diabetes mellitus: Exploring the challenges in the drug development process

Ashis Patnaik, J. A. Vaz · Perspectives in Clinical Research · 2012 · 22 citations · Full text

New Drug, Metabolic Syndrome, Translational Medicine +11

Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMix ^® study

Hak Chul Jang, S. R. Lee, J. A. Vaz · Diabetes Obesity and Metabolism · 2008 · 21 citations